vol.3 September 2020

KOBE Biomedical Innovation Cluster newsletter vol.3
- September 2020 -

Hello,

It has gotten cool in the mornings and nights finally here in Kobe, and we are starting to see the change in color of mountains and trees. We see autumn flowers are in bloom, and Cosmos is one of them. In Kanji (Chinese Character) , it is written with 2 characters as "秋桜", and they each mean "autumn" & "cherry blossom".

This is the 3rd issue of KBIC newsletter. If you missed the past news in KBIC, please visit KBIC Website "News and event" page (https://www.fbri-kobe.org/kbic/english/news/).

FBRI Editorial Team

News

FBRI and Fraunhofer IME signed a Joint Research Agreement on Drug Discovery for Dementia with Japanese Pharma Company

Foundation for Biomedical Research and Innovation at Kobe (FBRI), Fraunhofer Institute for Molecular Biology and Applied Ecology IME (Fraunhofer IME) and a Japanese pharmaceutical company has concluded the Joint Research Agreement on Drug Discovery for Dementia.　

Dr. Daichi Inoue of FBRI won American Society of Hematology Global Research Award

The Foundation for Biomedical Research and Innovation at Kobe is pleased to announce that Daichi Inoue., M.D., Ph.D., (Group Leader of Hematology-Oncology Department, Institute of Biomedical Research and Innovation, FBRI) has been selected by the American Society of Hermatology (ASH) to receive the 2020 ASH Global Research Award.　

Simulation results by the supercomputer “Fugaku” announced regarding the effects of masks and ventilation for prevention of droplet transmission

A new report has been received titled “Estimate of droplet transmission of virus in an indoor environment and preventive measures,” one of the researches to investigate preventive measures for COVID-19 infection using
the supercomputer “Fugaku.”

World's first clinical study begun in Kobe to transplant allogeneic iPS cell-derived retinal sheet for retinitis pigmentosa

The Kobe City Eye Hospital announced in June this year that the hospital had obtained approval from the Ministry of Health, Labour and Welfare for a clinical research plan to make iPS cell-derived neuroretinal sheets of photoreceptor cells which sense light, and to transplant the sheet to patients with an intractable eye disease, retinitis pigmentosa.